Chinese exports of traditional medicines hit $1.46 billion, says health official
Exports of traditional Chinese medicine (TCM) in the global market were valued at $1.46 billion last year, says Wang Guoqiang, Director of the State Administration of TCM, reported by the Xinhau news agency.
Mr Wang, who is also Vice Minister of Health, said the number of countries and regions which recognize the advantages and special features of TCM in treating modern diseases were on the rise and many countries were seeking cooperation with China on TCM.
Traditional Chinese medicines are mostly mixtures of a number of ingredients or medical plants such as herbs, which makes them much more difficult to explain and analyze in a quantitative sense than western drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze